ArticleJournal of ovarian research2026
Karyotype-based evaluation of ovarian reserve before ovarian tissue cryopreservation in Turner syndrome patients.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundTurner syndrome (TS) girls experience accelerated ovarian reserve depletion, exhibiting a strong demand for ovarian tissue cryopreservation (OTC) to preserve fertility and ovarian function. However, the current knowledge of OTC in TS is limited, and predicting follicular presence is insufficient. This study aims to investigate ovarian follicular reserve based on karyotypes, thereby contributing empirical data to informed decision-making in TS populations.
methodsThe retrospective case-control study comprised 26 TS patients and 52 age-matched non-TS (NTS) controls who underwent OTC between January 2022 and March 2025. The TS cohort included 45,X (n = 2), 45,X/46,XX (n = 6), and ‘other’ (n = 18), the latter encompassing 7 cases with 47,XXX mosaicism and 11 with structural X-chromosome abnormalities (SCA). Ovarian volume, estimated total follicle count (TFC), anti-Müllerian hormone (AMH), and follicle-stimulating hormone (FSH) were compared between the TS and NTS across age cohorts (0–5, 6–10, and > 10 years), and further analyzed across TS karyotype categories.
resultsFollicles were found in 91.7% of TS cases. Estimated TFC in TS showed no significant difference from NTS in the 0–5 age group. However, it was significantly reduced in TS aged 6–10 and > 10 years, reaching only 1.2% and 4.6% of NTS estimated TFC, respectively. The FSH levels (range 0.83–13.55 IU/L) in TS patients were elevated but below the diagnostic threshold for premature ovarian insufficiency, despite the absence of detectable follicles. No correlation was observed between AMH and estimated TFC. When comparing parameters across different karyotypes, the 45,X/46,XX group had the highest AMH, ovarian volume, and estimated TFC, which declined sharply with age (r = -0.858). Patients with a 45,X karyotype exhibited bilateral streak ovaries and no follicles. In 45,X/47,XXX, estimated TFC correlated positively with ovarian volume, independent of age (r = 0.922). TS with SCA generally exhibited low estimated TFC and AMH.
conclusionsOur findings suggest that ovarian reserve in TS is associated with karyotype, supporting the need for individualized counseling regarding OTC. Girls with 45,X appear to have a low probability of retaining follicles. For those with 45,X/46,XX mosaicism, the observed rapid decline in ovarian reserve suggests that timely consideration of OTC may be beneficial. In patients with 45,X/47,XXX, ovarian volume may be a helpful indicator for estimating TFC, potentially supporting OTC while ovarian volume remains substantial. Patients with SCA generally presented with reduced ovarian reserve in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.